Kathryn Weise, MD, MA

216.445.1404

Kathryn Weise, MD, MA

Appointed: 1997

Kathryn Weise, MD, MA
Department: Center for Ethics, Humanities and Spiritual Care
Location: Cleveland Clinic Main Campus
Mail Code JJ60
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.445.1404
WorkFax:216.444.9275
Kathryn Weise, MD, MA
Department: General Pediatrics
Location: Cleveland Clinic Main Campus
Mail Code JJ60
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.445.1404
Surgeon:
No
Treats:
Both Adults and Children & Adolescents

Biographical Sketch

Kathryn Weise, MD, is a pediatric intensivist who currently practices pediatric hospital medicine at the Cleveland Clinic Children’s Hospital for Rehabilitation. Her primary appointment is in the Department of Bioethics, where she is Program Director of the Cleveland Fellowship in Advanced Bioethics. She is a member of the Cleveland Clinic Ethics Committee, and chairs the Cleveland Clinic Pediatric Ethics Task Force.

Her medical school training was at The University of North Carolina in Chapel Hill, followed by residency in Pediatrics at Rainbow Babies and Children’s Hospital in Cleveland and fellowship in Pediatric Critical Care at the Children’s Hospital National Medical Center in Washington, DC. She practiced pediatric critical care at Rainbow Babies and Children’s Hospital in the Department of Pediatric Critical Care and Pharmacology, and the University of Virginia Department of Pediatric Critical Care before coming to the Cleveland Clinic in 1997. She completed a degree in Biomedical Ethics from the master’s program at Case Western Reserve University in 2000, has subsequently become adjunct faculty in the Department of Bioethics at Case and at Cleveland State University, and has served as a lecturer and clinical preceptor for the Case Bioethics Master of Arts program.

Regionally, she is the coordinator of the Northeast Ohio Regional Pediatric Ethics Consortium. Nationally, she is a member of the Bioethics Section of the American Academy of Pediatrics, is a member of the American Academy of Pediatrics Committee on Bioethics, and serves as an ethicist on several national data safety monitoring boards. She was formerly the Director of the Pediatric Palliative Medicine Service at the Children’s Hospital of the Cleveland Clinic, and is board-certified in that field. Her interests include pediatric critical care, pediatric end of life care, care of children with multiple handicaps, clinical ethics, and professional ethics.

Professional Highlights

  • Past Vice-Chair, Cleveland Clinic Foundation Ethics Committee
  • Program Director, Cleveland Fellowship in Advanced Bioethics

Education & Fellowships

Graduate - Case Western Reserve University
Biomedical Ethics
Cleveland, OH USA
2000
Fellowship - Children's Hospital National Medical Center
Pediatric Critical Care
Washington, DC USA
1987
Residency - Rainbow, Babies & Childrens University Hospitals
Pediatrics
Cleveland, OH USA
1985
Medical School - University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, NC USA
1982
Undergraduate - Kenyon College
Biology
Gambier, OH USA
1976

Certifications

  • Pediatrics

Specialty Interests

biomedical ethics, pediatric critical care, pediatric palliative medicine

Awards & Honors

  • Top Docs
  • >
  • Best Doctors in America

Additional Training

M.A. in Biomedical Ethics, Case Western Reserve University, 2000

Memberships

  • AAP
  • AMA
  • ASBH
  • BENO

Treatment & Services

  • Biomedical Ethics Consultation
  • Pediatric Hospital Medicine

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/2/2014, Dr. Weise has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Weise receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • National Institutes of Health (NIH)

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site